Medicare Enrolled
Dr. Mathew Cholankeril, MD
Cardiovascular Disease · Elizabeth, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cholankeril from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cholankeril?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cholankeril
Dr. Mathew Cholankeril is a cardiovascular disease specialist in Elizabeth, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cholankeril performed 3,799 Medicare services across 2,373 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cholankeril received a total of $18,959 from 41 pharmaceutical and/or device companies across 379 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cholankeril is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 28% volume in NJ
$18,959 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,799
Medicare services
Top 28% in NJ for cardiovascular disease
2,373
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~190 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
788 | $107 | $200 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
702 | $12 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
394 | $76 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
271 | $67 | $200 |
| Injection, dipyridamole, per 10 mg | 197 | $3 | $40 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
196 | $177 | $500 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
141 | $49 | $100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
123 | $402 | $900 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
120 | $136 | $296 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
87 | $55 | $350 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
80 | $65 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $140 | $250 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 49 | $20 | $100 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
48 | $34 | $40 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
44 | $7 | $85 |
| Cardiac catheterization | 40 | $211 | $2,000 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
40 | $153 | $350 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
39 | $33 | $70 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
39 | $7 | $100 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
38 | $219 | $350 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
37 | $12 | $300 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
36 | $181 | $400 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
34 | $93 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
27 | $8 | $10 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
27 | $11 | $110 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
27 | $111 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $100 | $250 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
24 | $157 | $350 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
23 | $455 | $2,417 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
19 | $12 | $150 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
18 | $64 | $100 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $244 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.3% high complexity
23.1% medium
69.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,959
Total received (2018-2024)
Avg $2,708/year across 7 years
Top 11% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
379
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,223 (59.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,976 (36.8%)
Other
Charitable contributions, space rental, and other categories
$693 (3.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$67 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,466
2023
$1,245
2022
$2,012
2021
$2,115
2020
$7,749
2019
$1,354
2018
$3,018
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$656
AstraZeneca Pharmaceuticals LP
$287
ShockWave Medical, Inc
$97
Novartis Pharmaceuticals Corporation
$69
Medtronic, Inc.
$64
Merck Sharp & Dohme LLC
$55
E.R. Squibb & Sons, L.L.C.
$41
Bayer Healthcare Pharmaceuticals Inc.
$41
Janssen Pharmaceuticals, Inc
$35
SCPHARMACEUTICALS INC.
$31
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$21
Edwards Lifesciences Corporation
$18
CORDIS US CORP.
$17
Penumbra, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 70.9% of 2024 payments
All-time payments by company (2018-2024) ›
GE Healthcare
$6,776
Abbott Laboratories
$2,666
AstraZeneca Pharmaceuticals LP
$2,190
Medtronic Vascular, Inc.
$1,145
BIOTRONIK INC.
$1,052
Novartis Pharmaceuticals Corporation
$706
Baxter Healthcare
$693
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$559
Novo Nordisk Inc
$300
Janssen Pharmaceuticals, Inc
$210
Boehringer Ingelheim Pharmaceuticals, Inc.
$201
Vifor Pharma, Inc.
$200
Merck Sharp & Dohme Corporation
$190
Merck Sharp & Dohme LLC
$171
Boston Scientific Corporation
$165
Shockwave Medical, Inc
$159
Amarin Pharma Inc.
$143
Medtronic, Inc.
$131
PFIZER INC.
$129
E.R. Squibb & Sons, L.L.C.
$115
Edwards Lifesciences Corporation
$115
Bayer HealthCare Pharmaceuticals Inc.
$107
Allergan Inc.
$102
Kowa Pharmaceuticals America, Inc.
$102
ShockWave Medical, Inc
$97
Bayer Healthcare Pharmaceuticals Inc.
$65
Lexicon Pharmaceuticals, Inc.
$55
BOSTON SCIENTIFIC CORPORATION
$54
Otsuka America Pharmaceutical, Inc.
$43
Lilly USA, LLC
$40
Daiichi Sankyo Inc.
$40
CORDIS US CORP.
$39
Penumbra, Inc.
$34
SCPHARMACEUTICALS INC.
$31
Bardy Diagnostics, Inc.
$30
Amgen Inc.
$29
ARALEZ PHARMACEUTICALS US INC.
$23
Mannkind Corporation
$15
GlaxoSmithKline, LLC.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Althera Pharmaceuticals LLC
$10
Top 3 companies account for 61.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ALLURE QUADRA · ASSURITY · AVEIR · AVYCAZ · Accent Pacemaker · Amplia MRI · Assurity Pacemaker · Azure · BASAGLAR · BEVESPI AEROSPHERE · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · COROFLOW · CRT-Ds · Carnation Ambulatory Monitor · ClosureFast · Confirm Rx · DURATA · Durata Defibrillation ICD Lead · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVEREST · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · FARXIGA · FUROSCIX · Fortify Assura · GALLANT · GENERAL STENTS · Gallant CRT-D · INJECTAFER · Indigo System · Inpefa · JANUVIA · JARDIANCE · JOT DX · Kerendia · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MERLIN@HOME · MYNXGRIP · Merlin Connectivity and Remote · Micra · Mitra Clip system · ONYX FRONTIER · Ozempic · PAXLOVID · PRADAXA · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · REXULTI · Repatha · Reveal LINQ · Roszet · Rybelsus · SAMSCA · SYMPLICITY G3 · Seglentis · Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave C2+ Coronary · TENDRIL · TRELEGY ELLIPTA · TRULICITY · Tresiba · VERQUVO · Vascepa · Vascular Lithotripsy · Veltassa · Victoza · Visia AF · WATCHMAN Access System · XARELTO · Xience Sierra Coronary Stent System · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (59%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
1,608
Per 100K population
280.8
County median income
$100,117
Nearest hospital
NEWARK BETH ISRAEL MEDICAL CENTER
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cholankeril is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NJ), with low-engagement industry engagement in the top 11% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cholankeril experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cholankeril performed 788 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cholankeril receive payments from pharmaceutical companies?
Yes. Dr. Cholankeril received a total of $18,959 from 41 companies across 379 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cholankeril's costs compare to other cardiologists in Elizabeth?
Dr. Cholankeril's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cholankeril) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Elizabeth
Browse cardiologists in Elizabeth ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
GE Healthcare Payments to Doctors
See all physicians who received payments from GE Healthcare.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology